Position in DNLI
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$5,144
-$20,634 QoQ
Shares Held
200
-65.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#244
of 290 holders
Holding Since
Sep 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HM PAYSON & CO holds $1,342,005 across 18 Biotechnology names. DNLI ranks #9 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,052 | $1,019,289 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
2,320 | $126,532 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
105 | $65,471 | |
| 4 | RCUS |
Arcus Biosciences, Inc.
|
1,700 | $52,411 | |
| 5 | ICCC |
Immucell Corp /De/
|
4,000 | $40,200 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
50 | $9,364 | |
| 7 | DBVT |
DBV Technologies S.A.
|
420 | $6,888 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
600 | $5,874 |
All Filings in DNLI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,144 | 200 | Shares | Sole | 2026-07-17 | |
| 2021-12-31 | $25,778 | 578 | Shares | Sole | 2022-02-15 | |
| 2021-03-31 | $57,842 | 1,013 | Shares | Sole | 2021-06-15 | |
| 2020-12-31 | $84,848 | 1,013 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $44,787 | 1,250 | Shares | Sole | 2020-12-21 | |
| No filing history on record for this holder in this stock. | ||||||